Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 903.00 10.95  | 1.23% 2.33% 32.22 25,510.82
NSE Price: Dec 09, 2016 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 09, 2016 903.00 10.95 1.23% 893.00 892.05 438,347 878.50 - 907.40
BSE Dec 09, 2016 904.10 13.35 1.50% 894.20 890.75 43,779 879.60 - 907.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 636,626 P/B: 6.23 NSE Code: GLENMARK
52-Week Range: R 671.10 - 994.00 Dividend Yield: 0.22% BSE Code: 532296
TTM EPS: R 28.06 Book Value: R 145.16 Face Value: R 1
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -2.05 0.39 0.70 2.33 19.28 24.24 12.56
S&P BSE Sensex 2.41 -1.85 -7.12 6.83 7.83 10.52 6.83
S&P BSE Healthcare -8.05 0.47 -6.29 -3.44 17.71 21.11 15.34
Company's return has been calculated on basis of NSE's price.
As on Dec 09, 2016
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.55 15.82 21.22
Net Profit 243.67 4.64 9.47
EPS 230.41 3.69 8.76
Book Value 64.77 2.02 7.52
Average
Operating Margin 18.83 18.55 18.90
Net Margin 9.30 7.20 9.14
Return on Networth 29.75 19.18 20.56
Return on Investment 19.04 15.49 15.72
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 14.46 16.48 -2.50
Operating Profit -1.77 10.47 42.19
Net Profit -1.41 3.48 30.53
EPS -1.41 3.46 30.38
TTM
Revenue 3.99 16.64 8.03
Operating Profit 2.74 20.42 9.11
Net Profit 0.96 50.98 6.94
EPS 0.95 49.54 6.93
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 25,510.82 8,204.78 791.60 9.55 29.75 6.23 32.22
Lupin 68,413.68 16,466.90 2,884.51 17.31 23.05 5.48 23.75
Sun Pharmaceutical Inds. 161,975.63 31,224.38 8,543.05 26.93 20.47 4.41 21.89
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Nov 09, 2016 Robin Pinto  Buy Market 500 899.50 4.50
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 1,500 765.30 11.48
Fund Houses invested in the stock
Fund Sep-16 Jun-16 Mar-16 Dec-15 Sep-15
Tata Mutual Fund 0.861 0.697 0.733 - 0.642
Sundaram Mutual Fund 0.279 0.256 0.256 0.256 0.214
SBI Mutual Fund 0.192 0.229 0.221 0.195 0.008
HDFC Mutual Fund 0.139 0.117 0.101 0.114 0.074
HSBC Mutual Fund 0.087 0.087 0.119 0.085 0.093
Kotak Mahindra Mutual Fund 0.063 0.098 0.040 0.101 0.115
Reliance Mutual Fund 0.043 0.007 0.017 0.033 0.003
IDFC Mutual Fund 0.031 0.049 0.061 0.056 0.245
ICICI Prudential Mutual Fund 0.031 0.025 0.003 0.013 0.012
UTI Mutual Fund 0.013 0.014 - - 0.052
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
4.28
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
32.22
5-Years Price to Book
6.23
Earnings Yield
EBIT / Enterprise value
4.67%
PEG
Price / Earnings to growth ratio
2.90
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R723.90 +0.47%
Cadila Healthcare R391.40 -1.09%
Cipla R578.90 -0.66%
Divi's Laboratories R1,161.50 +0.04%
Dr. Reddy's Lab R3,186.40 -0.79%
Glaxosmithkline Pharma R2,738.05 -0.05%
Lupin R1,511.55 -0.85%
Piramal Enterprises R1,719.90 -0.36%
Sun Pharmaceutical Inds. R673.00 -0.40%
Torrent Pharmaceuticals R1,339.35 -0.33%
As on Dec 09, 2016